stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Book value per share
Guardant Health, Inc.'s book value per share at the end of fiscal 2025 was −0.8×, compared with −1.1× in fiscal 2024. At the end of the quarter to 30 September 2026 it was −2.1×. Over the past ten years it has ranged from −1.1× (fiscal 2024) to 24.5× (fiscal 2017); the current reading is higher than 20% of that period. Guardant Health, Inc. ranks 48th of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | −0.8× | — |
| FY2024 | −1.1× | — |
| FY2023 | 1.4× | 140.58% |
| FY2022 | 0.6× | (90.75%) |
| FY2021 | 6.4× | (52.19%) |
| FY2020 | 13.3× | 51.12% |
| FY2019 | 8.8× | (44.55%) |
| FY2018 | 15.9× | (35.21%) |
| FY2017 | 24.5× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | −2.1× | — |
| Jun 2026 | −1.7× | — |
| Mar 2026 | −1.4× | — |
| Dec 2025 | −0.8× | — |
| 33 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICLR ICON PLC compare | 119× |
| LH Labcorp Holdings Inc. compare | 109× |
| DGX Quest Diagnostics Incorporated compare | 72.3× |
| CRL Charles River Laboratories International, Inc. compare | 67.6× |
| MEDP Medpace Holdings, Inc. compare | 20.9× |
| ILMN Illumina, Inc. compare | 20.8× |
| MTD Mettler-Toledo International, Inc. compare | 0.6× |
| RVTY Revvity Inc. compare | 0.0× |
| GH Guardant Health, Inc. | −2.1× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement